These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28400260)

  • 61. Olanzapine-induced changes in glucose metabolism are independent of the melanin-concentrating hormone system.
    Girault EM; Toonen PW; Eggels L; Foppen E; Ackermans MT; la Fleur SE; Fliers E; Kalsbeek A
    Psychoneuroendocrinology; 2013 Nov; 38(11):2640-6. PubMed ID: 23856185
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression.
    Han M; Deng C; Burne TH; Newell KA; Huang XF
    Psychoneuroendocrinology; 2008 Jun; 33(5):569-80. PubMed ID: 18358632
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 30 days of continuous olanzapine infusion determines energy imbalance, glucose intolerance, insulin resistance, and dyslipidemia in mice.
    Coccurello R; Brina D; Caprioli A; Conti R; Ghirardi O; Schepis F; Moles A
    J Clin Psychopharmacol; 2009 Dec; 29(6):576-83. PubMed ID: 19910724
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Protection from olanzapine-induced metabolic toxicity in mice by acetaminophen and tetrahydroindenoindole.
    Shertzer HG; Kendig EL; Nasrallah HA; Johansson E; Genter MB
    Int J Obes (Lond); 2010 Jun; 34(6):970-9. PubMed ID: 20065957
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Olanzapine Induced Dysmetabolic Changes Involving Tissue Chromium Mobilization in Female Rats.
    Yang CP; Wang YY; Lin SY; Hong YJ; Liao KY; Hsieh SK; Pan PH; Chen CJ; Chen WY
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717287
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities.
    Cooper GD; Pickavance LC; Wilding JP; Harrold JA; Halford JC; Goudie AJ
    J Psychopharmacol; 2007 Jun; 21(4):405-13. PubMed ID: 17050655
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Liraglutide prevents metabolic side-effects and improves recognition and working memory during antipsychotic treatment in rats.
    Babic I; Gorak A; Engel M; Sellers D; Else P; Osborne AL; Pai N; Huang XF; Nealon J; Weston-Green K
    J Psychopharmacol; 2018 May; 32(5):578-590. PubMed ID: 29493378
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Meal-induced insulin sensitization is preserved after acute olanzapine administration in female Sprague-Dawley rats.
    Kovács D; Hegedűs C; Kiss R; Sári R; Németh J; Szilvássy Z; Peitl B
    Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):525-30. PubMed ID: 25644372
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Protective effects of green tea on olanzapine-induced-metabolic syndrome in rats.
    Razavi BM; Lookian F; Hosseinzadeh H
    Biomed Pharmacother; 2017 Aug; 92():726-731. PubMed ID: 28586744
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Olanzapine, not resperidone, exacerbates beta-cell function and mass in ovariectomized diabetic rats and estrogen replacement reverses them.
    Park S; Sang Mee Hong ; Il Sung Ahn ; Sung Hoon Kim
    J Psychopharmacol; 2010 Jul; 24(7):1105-14. PubMed ID: 19965940
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Samidorphan mitigates olanzapine-induced weight gain and metabolic dysfunction in rats and non-human primates.
    Cunningham JI; Eyerman DJ; Todtenkopf MS; Dean RL; Deaver DR; Sanchez C; Namchuk M
    J Psychopharmacol; 2019 Oct; 33(10):1303-1316. PubMed ID: 31294646
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chronic Olanzapine Treatment Induces Disorders of Plasma Fatty Acid Profile in Balb/c Mice: A Potential Mechanism for Olanzapine-Induced Insulin Resistance.
    Li H; Fang M; Xu M; Li S; Du J; Li W; Chen H
    PLoS One; 2016; 11(12):e0167930. PubMed ID: 27973621
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Olanzapine increases cell mitotic activity and oligodendrocyte-lineage cells in the hypothalamus.
    Yamauchi T; Tatsumi K; Makinodan M; Kimoto S; Toritsuka M; Okuda H; Kishimoto T; Wanaka A
    Neurochem Int; 2010 Nov; 57(5):565-71. PubMed ID: 20643174
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Betahistine co-treatment ameliorates dyslipidemia induced by chronic olanzapine treatment in rats through modulation of hepatic AMPKα-SREBP-1 and PPARα-dependent pathways.
    Liu X; Lian J; Hu CH; Deng C
    Pharmacol Res; 2015 Oct; 100():36-46. PubMed ID: 26218603
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Olanzapine impairs glycogen synthesis and insulin signaling in L6 skeletal muscle cells.
    Engl J; Laimer M; Niederwanger A; Kranebitter M; Starzinger M; Pedrini MT; Fleischhacker WW; Patsch JR; Ebenbichler CF
    Mol Psychiatry; 2005 Dec; 10(12):1089-96. PubMed ID: 16130009
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats.
    Choi S; DiSilvio B; Unangst J; Fernstrom JD
    Life Sci; 2007 Sep; 81(12):1024-30. PubMed ID: 17822717
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Metabolic side-effects of the novel second-generation antipsychotic drugs asenapine and iloperidone: a comparison with olanzapine.
    Boyda HN; Procyshyn RM; Pang CC; Hawkes E; Wong D; Jin CH; Honer WG; Barr AM
    PLoS One; 2013; 8(1):e53459. PubMed ID: 23326434
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Olanzapine activates hepatic mammalian target of rapamycin: new mechanistic insight into metabolic dysregulation with atypical antipsychotic drugs.
    Schmidt RH; Jokinen JD; Massey VL; Falkner KC; Shi X; Yin X; Zhang X; Beier JI; Arteel GE
    J Pharmacol Exp Ther; 2013 Oct; 347(1):126-35. PubMed ID: 23926289
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of second-generation antipsychotics on human subcutaneous adipose tissue metabolism.
    Sarsenbayeva A; Marques-Santos CM; Thombare K; Di Nunzio G; Almby KE; Lundqvist M; Eriksson JW; Pereira MJ
    Psychoneuroendocrinology; 2019 Dec; 110():104445. PubMed ID: 31563732
    [TBL] [Abstract][Full Text] [Related]  

  • 80. GLP1 receptor agonism protects against acute olanzapine-induced hyperglycemia.
    Medak KD; Shamshoum H; Peppler WT; Wright DC
    Am J Physiol Endocrinol Metab; 2020 Dec; 319(6):E1101-E1111. PubMed ID: 33017220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.